Abstract:Purpose: The aim of this study is to evaluate the performance of free-breathing liver MRI with a novel respiratory frequency-modulated continuous-wave radar-trigger (FT) technique on T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) for both healthy volunteers and patients in comparison to navigator-trigger (NT) and belt-trigger (BT) techniques. Methods: In this prospective study, 17 healthy volunteers and 23 patients with known or suspected liver diseases were enrolled. Six sequences (T2WI and DWI with FT, NT, and BT techniques) were performed in each subject. Quantitative evaluation and qualitative assessment were analyzed by two radiologists. Overall image quality, blurring, motion artifacts, and liver edge delineations were rated on a 4-point Likert scale. The liver and lesion signal-to-noise ratio (SNR), the lesion-to-liver contrast-to-noise ratio (CNR), as well as the apparent diffusion coefficient (ADC) value were quantitatively calculated. Results: For volunteers, there were no significant differences in the image quality Likert scores and quantitative parameters on T2WI and DWI with three respiratory-trigger techniques. For patients, NT was superior to other techniques for image quality on T2WI; conversely, little difference was found on DWI in qualitative assessment. The mean SNR of the liver on T2WI and DWI with BT, NT, and FT techniques was similar in patients, which is in line with volunteers. FT performed better in terms of higher SNR (705.13 ± 434.80) and higher CNR (504.41 ± 400.69) on DWI at b50 compared with BT (SNR: 651.83 ± 401.16; CNR:429.24 ± 404.11) and NT (SNR: 639.41 ± 407.98; CNR: 420.64 ± 416.61) ( p < 0.05). The mean ADC values of the liver and lesion with different techniques in both volunteers and patients showed non-significant difference. Conclusion: For volunteers, the performance of T2WI as well as DWI with three respiratory-trigger techniques was similarly good. As for patients, FT-DWI is superior to BT and NT techniques in terms of higher lesion SNR and CNR at b50.

~(13)C Breath Test:A New Noninvasive Method for Liver Mitochondrial Function Assessment

Optimization of Volatile Markers of Lung Cancer to Exclude Interferences of Non-Malignant Disease

Role of ~(13)C-methacetin Breath Test in the Assessment of Liver Function

Free-breathing liver fat quantification using a multiecho 3D stack-of-radial technique.

A Quantitative Assessment of Liver Function Using L-[1-13C]phenylalanine Breath Test

Research on Parameters of L-[1-13C] Phenylalanine Breath Test for Quantitative Assessment of Liver Function in Adult

Clinical Research on Liver Reserve Function by 13C-Phenylalanine Breath Test in Aged Patients with Chronic Liver Diseases

Study on Parameters of L-[1-^13C]phenylalanine Breath Test for Quantitative Assessment of Liver Function in Healthy Subjects and Patients with Hepatitis B Virus-Related Liver Disease

A compact breath breathalyzer for identifying the non-alcoholic fatty liver disease biomarker

In Vivo Assessment of Mitochondrial Function

Noninvasive Strategy Based on Real-Time in Vivo Cataluminescence Monitoring for Clinical Breath Analysis.

A proton nuclear magnetic resonance metabonomics approach for biomarker discovery in nonalcoholic fatty liver disease.

Development and Validation of a Novel Non-Invasive Test for Diagnosing Nonalcoholic Fatty Liver Disease in Chinese Children

Clinical Practice of L-1-13C-phenylalanine in Staging of Chronic Liver Disease

Non-invasive testing in metabolic dysfunction-associated steatotic liver disease

Free-Breathing Liver Magnetic Resonance Imaging With Respiratory Frequency-Modulated Continuous-Wave Radar-Trigger Technique: A Preliminary Study

13C-methacetin breath test for evaluating of children's liver disorder

Gd-EOB-DTPA-enhanced T1 relaxometry for assessment of liver function determined by real-time 13C-methacetin breath test

Prospect and Challenges of Volatile Organic Compound Breath Testing in Non-Cancer Gastrointestinal Disorders

A novel and robust method for assessing mitochondrial (dys)function in healthy and diseased frozen cardiac tissue

Progress in Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease